Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

960 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial.
Lee YJ, Cho JY, You SC, Lee YH, Yun KH, Cho YH, Shin WY, Im SW, Kang WC, Park Y, Lee SY, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS. Lee YJ, et al. Among authors: hong mk, hong sj. Eur Heart J. 2023 Mar 14;44(11):972-983. doi: 10.1093/eurheartj/ehac709. Eur Heart J. 2023. PMID: 36529993 Clinical Trial.
A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. Park SJ, et al. Among authors: hong mk. N Engl J Med. 2003 Apr 17;348(16):1537-45. doi: 10.1056/NEJMoa021007. N Engl J Med. 2003. PMID: 12700373 Free article. Clinical Trial.
A multicenter, randomized, open-label, therapeutic, and exploratory trial to evaluate the tolerability and efficacy of platelet glycoprotein IIb/IIIa receptor blocker (Clotinab) in high-risk patients with percutaneous coronary intervention.
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y. Moon JY, et al. Among authors: hong mk. Yonsei Med J. 2008 Jun 30;49(3):389-99. doi: 10.3349/ymj.2008.49.3.389. Yonsei Med J. 2008. PMID: 18581587 Free PMC article. Clinical Trial.
Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, Park SW, Seung KB, Gwon HC, Jeong MH, Jang Y, Kim HS, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ; Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators. Kim YH, et al. Among authors: hong mk. Circulation. 2009 Aug 4;120(5):400-7. doi: 10.1161/CIRCULATIONAHA.108.800805. Epub 2009 Jul 20. Circulation. 2009. PMID: 19620506
Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study.
Kim JS, Fan C, Choi D, Jang IK, Lee JM, Kim TH, Park SM, Paik SI, Ko YG, Hong MK, Jang Y, Chung N. Kim JS, et al. Among authors: hong mk. Int J Cardiol. 2011 Feb 3;146(3):341-6. doi: 10.1016/j.ijcard.2009.07.012. Epub 2009 Aug 25. Int J Cardiol. 2011. PMID: 19709765
960 results